img

Global Autoimmune Disease Diagnostics Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Autoimmune Disease Diagnostics Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

The diagnosis of autoimmune diseases depends on the identification of disease-associated clinical symptoms and is associated with the detection of autoantibodies. Clinicians conventionally classify autoimmune diseases as either systemic or organ-specific.
Autoimmune Disease Diagnostics report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Autoimmune Disease Diagnostics market is projected to reach US$ 6801.2 million in 2034, increasing from US$ 4906.4 million in 2022, with the CAGR of 4.7% during the period of 2024 to 2034. Demand from Hospitals and Research Laboratories are the major drivers for the industry.
In terms of geography, the Americas led the global autoimmune disease diagnostics market and will continue to dominate the market in the coming years. The growing incidence of autoimmune disorders such as RA, SLE, and IBD will aid in the growth of this market. Also, the extensive R&D activities has allowed the launch of novel diagnostic products, which are expected to drive the adoption rates for autoimmune diagnostics in the Americas.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Autoimmune Disease Diagnostics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Abbott Laboratories
Beckman Coulter
Bio-Rad Laboratories
EUROIMMUN
Inova Diagnostics
Roche Diagnostics
Siemens Healthcare
DiaSorin
ERBA Diagnostics
Euro Diagnostica
Autoimmune Technologies
Avant Diagnostics
Exagen Diagnostics
Gold Standard Diagnostics
HOB Diagnostics
HUMAN Diagnostics
Immco Diagnostics
ImmunArray
Myriad Genetics
Omega Diagnostics
ORGENTEC Diagnostika
Phadia
Protagen
Segment by Type
Analyzers
Assay Kits

Segment by Application


Hospitals
Research Laboratories
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Autoimmune Disease Diagnostics market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Autoimmune Disease Diagnostics introduction, etc. Autoimmune Disease Diagnostics Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Autoimmune Disease Diagnostics market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Autoimmune Disease Diagnostics
1.1 Autoimmune Disease Diagnostics Market Overview
1.1.1 Autoimmune Disease Diagnostics Product Scope
1.1.2 Autoimmune Disease Diagnostics Market Status and Outlook
1.2 Global Autoimmune Disease Diagnostics Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Autoimmune Disease Diagnostics Market Size by Region (2024-2034)
1.4 Global Autoimmune Disease Diagnostics Historic Market Size by Region (2024-2024)
1.5 Global Autoimmune Disease Diagnostics Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Autoimmune Disease Diagnostics Market Size (2024-2034)
1.6.1 North America Autoimmune Disease Diagnostics Market Size (2024-2034)
1.6.2 Europe Autoimmune Disease Diagnostics Market Size (2024-2034)
1.6.3 Asia-Pacific Autoimmune Disease Diagnostics Market Size (2024-2034)
1.6.4 Latin America Autoimmune Disease Diagnostics Market Size (2024-2034)
1.6.5 Middle East & Africa Autoimmune Disease Diagnostics Market Size (2024-2034)
2 Autoimmune Disease Diagnostics Market by Type
2.1 Introduction
2.1.1 Analyzers
2.1.2 Assay Kits
2.2 Global Autoimmune Disease Diagnostics Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Autoimmune Disease Diagnostics Historic Market Size by Type (2024-2024)
2.2.2 Global Autoimmune Disease Diagnostics Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Autoimmune Disease Diagnostics Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Autoimmune Disease Diagnostics Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Autoimmune Disease Diagnostics Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Autoimmune Disease Diagnostics Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Autoimmune Disease Diagnostics Revenue Breakdown by Type (2024-2034)
3 Autoimmune Disease Diagnostics Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Research Laboratories
3.2 Global Autoimmune Disease Diagnostics Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Autoimmune Disease Diagnostics Historic Market Size by Application (2024-2024)
3.2.2 Global Autoimmune Disease Diagnostics Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Autoimmune Disease Diagnostics Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Autoimmune Disease Diagnostics Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Autoimmune Disease Diagnostics Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Autoimmune Disease Diagnostics Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Autoimmune Disease Diagnostics Revenue Breakdown by Application (2024-2034)
4 Autoimmune Disease Diagnostics Competition Analysis by Players
4.1 Global Autoimmune Disease Diagnostics Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Autoimmune Disease Diagnostics as of 2022)
4.3 Date of Key Players Enter into Autoimmune Disease Diagnostics Market
4.4 Global Top Players Autoimmune Disease Diagnostics Headquarters and Area Served
4.5 Key Players Autoimmune Disease Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Autoimmune Disease Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Autoimmune Disease Diagnostics Products, Services and Solutions
5.1.4 Abbott Laboratories Autoimmune Disease Diagnostics Revenue (US$ Million) & (2024-2024)
5.1.5 Abbott Laboratories Recent Developments
5.2 Beckman Coulter
5.2.1 Beckman Coulter Profile
5.2.2 Beckman Coulter Main Business
5.2.3 Beckman Coulter Autoimmune Disease Diagnostics Products, Services and Solutions
5.2.4 Beckman Coulter Autoimmune Disease Diagnostics Revenue (US$ Million) & (2024-2024)
5.2.5 Beckman Coulter Recent Developments
5.3 Bio-Rad Laboratories
5.3.1 Bio-Rad Laboratories Profile
5.3.2 Bio-Rad Laboratories Main Business
5.3.3 Bio-Rad Laboratories Autoimmune Disease Diagnostics Products, Services and Solutions
5.3.4 Bio-Rad Laboratories Autoimmune Disease Diagnostics Revenue (US$ Million) & (2024-2024)
5.3.5 EUROIMMUN Recent Developments
5.4 EUROIMMUN
5.4.1 EUROIMMUN Profile
5.4.2 EUROIMMUN Main Business
5.4.3 EUROIMMUN Autoimmune Disease Diagnostics Products, Services and Solutions
5.4.4 EUROIMMUN Autoimmune Disease Diagnostics Revenue (US$ Million) & (2024-2024)
5.4.5 EUROIMMUN Recent Developments
5.5 Inova Diagnostics
5.5.1 Inova Diagnostics Profile
5.5.2 Inova Diagnostics Main Business
5.5.3 Inova Diagnostics Autoimmune Disease Diagnostics Products, Services and Solutions
5.5.4 Inova Diagnostics Autoimmune Disease Diagnostics Revenue (US$ Million) & (2024-2024)
5.5.5 Inova Diagnostics Recent Developments
5.6 Roche Diagnostics
5.6.1 Roche Diagnostics Profile
5.6.2 Roche Diagnostics Main Business
5.6.3 Roche Diagnostics Autoimmune Disease Diagnostics Products, Services and Solutions
5.6.4 Roche Diagnostics Autoimmune Disease Diagnostics Revenue (US$ Million) & (2024-2024)
5.6.5 Roche Diagnostics Recent Developments
5.7 Siemens Healthcare
5.7.1 Siemens Healthcare Profile
5.7.2 Siemens Healthcare Main Business
5.7.3 Siemens Healthcare Autoimmune Disease Diagnostics Products, Services and Solutions
5.7.4 Siemens Healthcare Autoimmune Disease Diagnostics Revenue (US$ Million) & (2024-2024)
5.7.5 Siemens Healthcare Recent Developments
5.8 DiaSorin
5.8.1 DiaSorin Profile
5.8.2 DiaSorin Main Business
5.8.3 DiaSorin Autoimmune Disease Diagnostics Products, Services and Solutions
5.8.4 DiaSorin Autoimmune Disease Diagnostics Revenue (US$ Million) & (2024-2024)
5.8.5 DiaSorin Recent Developments
5.9 ERBA Diagnostics
5.9.1 ERBA Diagnostics Profile
5.9.2 ERBA Diagnostics Main Business
5.9.3 ERBA Diagnostics Autoimmune Disease Diagnostics Products, Services and Solutions
5.9.4 ERBA Diagnostics Autoimmune Disease Diagnostics Revenue (US$ Million) & (2024-2024)
5.9.5 ERBA Diagnostics Recent Developments
5.10 Euro Diagnostica
5.10.1 Euro Diagnostica Profile
5.10.2 Euro Diagnostica Main Business
5.10.3 Euro Diagnostica Autoimmune Disease Diagnostics Products, Services and Solutions
5.10.4 Euro Diagnostica Autoimmune Disease Diagnostics Revenue (US$ Million) & (2024-2024)
5.10.5 Euro Diagnostica Recent Developments
5.11 Autoimmune Technologies
5.11.1 Autoimmune Technologies Profile
5.11.2 Autoimmune Technologies Main Business
5.11.3 Autoimmune Technologies Autoimmune Disease Diagnostics Products, Services and Solutions
5.11.4 Autoimmune Technologies Autoimmune Disease Diagnostics Revenue (US$ Million) & (2024-2024)
5.11.5 Autoimmune Technologies Recent Developments
5.12 Avant Diagnostics
5.12.1 Avant Diagnostics Profile
5.12.2 Avant Diagnostics Main Business
5.12.3 Avant Diagnostics Autoimmune Disease Diagnostics Products, Services and Solutions
5.12.4 Avant Diagnostics Autoimmune Disease Diagnostics Revenue (US$ Million) & (2024-2024)
5.12.5 Avant Diagnostics Recent Developments
5.13 Exagen Diagnostics
5.13.1 Exagen Diagnostics Profile
5.13.2 Exagen Diagnostics Main Business
5.13.3 Exagen Diagnostics Autoimmune Disease Diagnostics Products, Services and Solutions
5.13.4 Exagen Diagnostics Autoimmune Disease Diagnostics Revenue (US$ Million) & (2024-2024)
5.13.5 Exagen Diagnostics Recent Developments
5.14 Gold Standard Diagnostics
5.14.1 Gold Standard Diagnostics Profile
5.14.2 Gold Standard Diagnostics Main Business
5.14.3 Gold Standard Diagnostics Autoimmune Disease Diagnostics Products, Services and Solutions
5.14.4 Gold Standard Diagnostics Autoimmune Disease Diagnostics Revenue (US$ Million) & (2024-2024)
5.14.5 Gold Standard Diagnostics Recent Developments
5.15 HOB Diagnostics
5.15.1 HOB Diagnostics Profile
5.15.2 HOB Diagnostics Main Business
5.15.3 HOB Diagnostics Autoimmune Disease Diagnostics Products, Services and Solutions
5.15.4 HOB Diagnostics Autoimmune Disease Diagnostics Revenue (US$ Million) & (2024-2024)
5.15.5 HOB Diagnostics Recent Developments
5.16 HUMAN Diagnostics
5.16.1 HUMAN Diagnostics Profile
5.16.2 HUMAN Diagnostics Main Business
5.16.3 HUMAN Diagnostics Autoimmune Disease Diagnostics Products, Services and Solutions
5.16.4 HUMAN Diagnostics Autoimmune Disease Diagnostics Revenue (US$ Million) & (2024-2024)
5.16.5 HUMAN Diagnostics Recent Developments
5.17 Immco Diagnostics
5.17.1 Immco Diagnostics Profile
5.17.2 Immco Diagnostics Main Business
5.17.3 Immco Diagnostics Autoimmune Disease Diagnostics Products, Services and Solutions
5.17.4 Immco Diagnostics Autoimmune Disease Diagnostics Revenue (US$ Million) & (2024-2024)
5.17.5 Immco Diagnostics Recent Developments
5.18 ImmunArray
5.18.1 ImmunArray Profile
5.18.2 ImmunArray Main Business
5.18.3 ImmunArray Autoimmune Disease Diagnostics Products, Services and Solutions
5.18.4 ImmunArray Autoimmune Disease Diagnostics Revenue (US$ Million) & (2024-2024)
5.18.5 ImmunArray Recent Developments
5.19 Myriad Genetics
5.19.1 Myriad Genetics Profile
5.19.2 Myriad Genetics Main Business
5.19.3 Myriad Genetics Autoimmune Disease Diagnostics Products, Services and Solutions
5.19.4 Myriad Genetics Autoimmune Disease Diagnostics Revenue (US$ Million) & (2024-2024)
5.19.5 Myriad Genetics Recent Developments
5.20 Omega Diagnostics
5.20.1 Omega Diagnostics Profile
5.20.2 Omega Diagnostics Main Business
5.20.3 Omega Diagnostics Autoimmune Disease Diagnostics Products, Services and Solutions
5.20.4 Omega Diagnostics Autoimmune Disease Diagnostics Revenue (US$ Million) & (2024-2024)
5.20.5 Omega Diagnostics Recent Developments
5.21 ORGENTEC Diagnostika
5.21.1 ORGENTEC Diagnostika Profile
5.21.2 ORGENTEC Diagnostika Main Business
5.21.3 ORGENTEC Diagnostika Autoimmune Disease Diagnostics Products, Services and Solutions
5.21.4 ORGENTEC Diagnostika Autoimmune Disease Diagnostics Revenue (US$ Million) & (2024-2024)
5.21.5 ORGENTEC Diagnostika Recent Developments
5.22 Phadia
5.22.1 Phadia Profile
5.22.2 Phadia Main Business
5.22.3 Phadia Autoimmune Disease Diagnostics Products, Services and Solutions
5.22.4 Phadia Autoimmune Disease Diagnostics Revenue (US$ Million) & (2024-2024)
5.22.5 Phadia Recent Developments
5.23 Protagen
5.23.1 Protagen Profile
5.23.2 Protagen Main Business
5.23.3 Protagen Autoimmune Disease Diagnostics Products, Services and Solutions
5.23.4 Protagen Autoimmune Disease Diagnostics Revenue (US$ Million) & (2024-2024)
5.23.5 Protagen Recent Developments
6 North America
6.1 North America Autoimmune Disease Diagnostics Market Size by Country (2024-2034)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Autoimmune Disease Diagnostics Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Autoimmune Disease Diagnostics Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Autoimmune Disease Diagnostics Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Autoimmune Disease Diagnostics Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Autoimmune Disease Diagnostics Market Dynamics
11.1 Autoimmune Disease Diagnostics Industry Trends
11.2 Autoimmune Disease Diagnostics Market Drivers
11.3 Autoimmune Disease Diagnostics Market Challenges
11.4 Autoimmune Disease Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Autoimmune Disease Diagnostics Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Autoimmune Disease Diagnostics Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Autoimmune Disease Diagnostics Market Size Share by Region (2024-2024)
Table 4. Global Autoimmune Disease Diagnostics Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Autoimmune Disease Diagnostics Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Autoimmune Disease Diagnostics Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Autoimmune Disease Diagnostics Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Autoimmune Disease Diagnostics Revenue Market Share by Type (2024-2024)
Table 9. Global Autoimmune Disease Diagnostics Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Autoimmune Disease Diagnostics Revenue Market Share by Type (2024-2034)
Table 11. North America Autoimmune Disease Diagnostics Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Autoimmune Disease Diagnostics Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Autoimmune Disease Diagnostics Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Autoimmune Disease Diagnostics Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Autoimmune Disease Diagnostics Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Autoimmune Disease Diagnostics Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Autoimmune Disease Diagnostics Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Autoimmune Disease Diagnostics Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Autoimmune Disease Diagnostics Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Autoimmune Disease Diagnostics Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Autoimmune Disease Diagnostics Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Autoimmune Disease Diagnostics Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Autoimmune Disease Diagnostics Revenue Market Share by Application (2024-2024)
Table 24. Global Autoimmune Disease Diagnostics Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Autoimmune Disease Diagnostics Revenue Market Share by Application (2024-2034)
Table 26. North America Autoimmune Disease Diagnostics Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Autoimmune Disease Diagnostics Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Autoimmune Disease Diagnostics Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Autoimmune Disease Diagnostics Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Autoimmune Disease Diagnostics Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Autoimmune Disease Diagnostics Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Autoimmune Disease Diagnostics Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Autoimmune Disease Diagnostics Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Autoimmune Disease Diagnostics Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Autoimmune Disease Diagnostics Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Autoimmune Disease Diagnostics Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Autoimmune Disease Diagnostics Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Autoimmune Disease Diagnostics as of 2022)
Table 39. Date of Key Players Enter into Autoimmune Disease Diagnostics Market
Table 40. Global Autoimmune Disease Diagnostics Key Players Headquarters and Area Served
Table 41. Autoimmune Disease Diagnostics Product Solution and Service
Table 42. Global Autoimmune Disease Diagnostics Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Abbott Laboratories Basic Information List
Table 45. Abbott Laboratories Description and Business Overview
Table 46. Abbott Laboratories Autoimmune Disease Diagnostics Products, Services and Solutions
Table 47. Revenue (US$ Million) in Autoimmune Disease Diagnostics Business of Abbott Laboratories (2024-2024)
Table 48. Abbott Laboratories Recent Developments
Table 49. Beckman Coulter Basic Information List
Table 50. Beckman Coulter Description and Business Overview
Table 51. Beckman Coulter Autoimmune Disease Diagnostics Products, Services and Solutions
Table 52. Revenue (US$ Million) in Autoimmune Disease Diagnostics Business of Beckman Coulter (2024-2024)
Table 53. Beckman Coulter Recent Developments
Table 54. Bio-Rad Laboratories Basic Information List
Table 55. Bio-Rad Laboratories Description and Business Overview
Table 56. Bio-Rad Laboratories Autoimmune Disease Diagnostics Products, Services and Solutions
Table 57. Revenue (US$ Million) in Autoimmune Disease Diagnostics Business of Bio-Rad Laboratories (2024-2024)
Table 58. Bio-Rad Laboratories Recent Developments
Table 59. EUROIMMUN Basic Information List
Table 60. EUROIMMUN Description and Business Overview
Table 61. EUROIMMUN Autoimmune Disease Diagnostics Products, Services and Solutions
Table 62. Revenue (US$ Million) in Autoimmune Disease Diagnostics Business of EUROIMMUN (2024-2024)
Table 63. EUROIMMUN Recent Developments
Table 64. Inova Diagnostics Basic Information List
Table 65. Inova Diagnostics Description and Business Overview
Table 66. Inova Diagnostics Autoimmune Disease Diagnostics Products, Services and Solutions
Table 67. Revenue (US$ Million) in Autoimmune Disease Diagnostics Business of Inova Diagnostics (2024-2024)
Table 68. Inova Diagnostics Recent Developments
Table 69. Roche Diagnostics Basic Information List
Table 70. Roche Diagnostics Description and Business Overview
Table 71. Roche Diagnostics Autoimmune Disease Diagnostics Products, Services and Solutions
Table 72. Revenue (US$ Million) in Autoimmune Disease Diagnostics Business of Roche Diagnostics (2024-2024)
Table 73. Roche Diagnostics Recent Developments
Table 74. Siemens Healthcare Basic Information List
Table 75. Siemens Healthcare Description and Business Overview
Table 76. Siemens Healthcare Autoimmune Disease Diagnostics Products, Services and Solutions
Table 77. Revenue (US$ Million) in Autoimmune Disease Diagnostics Business of Siemens Healthcare (2024-2024)
Table 78. Siemens Healthcare Recent Developments
Table 79. DiaSorin Basic Information List
Table 80. DiaSorin Description and Business Overview
Table 81. DiaSorin Autoimmune Disease Diagnostics Products, Services and Solutions
Table 82. Revenue (US$ Million) in Autoimmune Disease Diagnostics Business of DiaSorin (2024-2024)
Table 83. DiaSorin Recent Developments
Table 84. ERBA Diagnostics Basic Information List
Table 85. ERBA Diagnostics Description and Business Overview
Table 86. ERBA Diagnostics Autoimmune Disease Diagnostics Products, Services and Solutions
Table 87. Revenue (US$ Million) in Autoimmune Disease Diagnostics Business of ERBA Diagnostics (2024-2024)
Table 88. ERBA Diagnostics Recent Developments
Table 89. Euro Diagnostica Basic Information List
Table 90. Euro Diagnostica Description and Business Overview
Table 91. Euro Diagnostica Autoimmune Disease Diagnostics Products, Services and Solutions
Table 92. Revenue (US$ Million) in Autoimmune Disease Diagnostics Business of Euro Diagnostica (2024-2024)
Table 93. Euro Diagnostica Recent Developments
Table 94. Autoimmune Technologies Basic Information List
Table 95. Autoimmune Technologies Description and Business Overview
Table 96. Autoimmune Technologies Autoimmune Disease Diagnostics Products, Services and Solutions
Table 97. Revenue (US$ Million) in Autoimmune Disease Diagnostics Business of Autoimmune Technologies (2024-2024)
Table 98. Autoimmune Technologies Recent Developments
Table 99. Avant Diagnostics Basic Information List
Table 100. Avant Diagnostics Description and Business Overview
Table 101. Avant Diagnostics Autoimmune Disease Diagnostics Products, Services and Solutions
Table 102. Revenue (US$ Million) in Autoimmune Disease Diagnostics Business of Avant Diagnostics (2024-2024)
Table 103. Avant Diagnostics Recent Developments
Table 104. Exagen Diagnostics Basic Information List
Table 105. Exagen Diagnostics Description and Business Overview
Table 106. Exagen Diagnostics Autoimmune Disease Diagnostics Products, Services and Solutions
Table 107. Revenue (US$ Million) in Autoimmune Disease Diagnostics Business of Exagen Diagnostics (2024-2024)
Table 108. Exagen Diagnostics Recent Developments
Table 109. Gold Standard Diagnostics Basic Information List
Table 110. Gold Standard Diagnostics Description and Business Overview
Table 111. Gold Standard Diagnostics Autoimmune Disease Diagnostics Products, Services and Solutions
Table 112. Revenue (US$ Million) in Autoimmune Disease Diagnostics Business of Gold Standard Diagnostics (2024-2024)
Table 113. Gold Standard Diagnostics Recent Developments
Table 114. HOB Diagnostics Basic Information List
Table 115. HOB Diagnostics Description and Business Overview
Table 116. HOB Diagnostics Autoimmune Disease Diagnostics Products, Services and Solutions
Table 117. Revenue (US$ Million) in Autoimmune Disease Diagnostics Business of HOB Diagnostics (2024-2024)
Table 118. HOB Diagnostics Recent Developments
Table 119. HUMAN Diagnostics Basic Information List
Table 120. HUMAN Diagnostics Description and Business Overview
Table 121. HUMAN Diagnostics Autoimmune Disease Diagnostics Products, Services and Solutions
Table 122. Revenue (US$ Million) in Autoimmune Disease Diagnostics Business of HUMAN Diagnostics (2024-2024)
Table 123. HUMAN Diagnostics Recent Developments
Table 124. Immco Diagnostics Basic Information List
Table 125. Immco Diagnostics Description and Business Overview
Table 126. Immco Diagnostics Autoimmune Disease Diagnostics Products, Services and Solutions
Table 127. Revenue (US$ Million) in Autoimmune Disease Diagnostics Business of Immco Diagnostics (2024-2024)
Table 128. Immco Diagnostics Recent Developments
Table 129. ImmunArray Basic Information List
Table 130. ImmunArray Description and Business Overview
Table 131. ImmunArray Autoimmune Disease Diagnostics Products, Services and Solutions
Table 132. Revenue (US$ Million) in Autoimmune Disease Diagnostics Business of ImmunArray (2024-2024)
Table 133. ImmunArray Recent Developments
Table 134. Myriad Genetics Basic Information List
Table 135. Myriad Genetics Description and Business Overview
Table 136. Myriad Genetics Autoimmune Disease Diagnostics Products, Services and Solutions
Table 137. Revenue (US$ Million) in Autoimmune Disease Diagnostics Business of Myriad Genetics (2024-2024)
Table 138. Myriad Genetics Recent Developments
Table 139. Omega Diagnostics Basic Information List
Table 140. Omega Diagnostics Description and Business Overview
Table 141. Omega Diagnostics Autoimmune Disease Diagnostics Products, Services and Solutions
Table 142. Revenue (US$ Million) in Autoimmune Disease Diagnostics Business of Omega Diagnostics (2024-2024)
Table 143. Omega Diagnostics Recent Developments
Table 144. ORGENTEC Diagnostika Basic Information List
Table 145. ORGENTEC Diagnostika Description and Business Overview
Table 146. ORGENTEC Diagnostika Autoimmune Disease Diagnostics Products, Services and Solutions
Table 147. Revenue (US$ Million) in Autoimmune Disease Diagnostics Business of ORGENTEC Diagnostika (2024-2024)
Table 148. ORGENTEC Diagnostika Recent Developments
Table 149. Phadia Basic Information List
Table 150. Phadia Description and Business Overview
Table 151. Phadia Autoimmune Disease Diagnostics Products, Services and Solutions
Table 152. Revenue (US$ Million) in Autoimmune Disease Diagnostics Business of Phadia (2024-2024)
Table 153. Phadia Recent Developments
Table 154. Protagen Basic Information List
Table 155. Protagen Description and Business Overview
Table 156. Protagen Autoimmune Disease Diagnostics Products, Services and Solutions
Table 157. Revenue (US$ Million) in Autoimmune Disease Diagnostics Business of Protagen (2024-2024)
Table 158. Protagen Recent Developments
Table 159. North America Autoimmune Disease Diagnostics Market Size by Country (2024-2024) & (US$ Million)
Table 160. North America Autoimmune Disease Diagnostics Market Size by Country (2024-2034) & (US$ Million)
Table 161. Europe Autoimmune Disease Diagnostics Market Size by Country (2024-2024) & (US$ Million)
Table 162. Europe Autoimmune Disease Diagnostics Market Size by Country (2024-2034) & (US$ Million)
Table 163. Asia-Pacific Autoimmune Disease Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 164. Asia-Pacific Autoimmune Disease Diagnostics Market Size by Region (2024-2024) & (US$ Million)
Table 165. Asia-Pacific Autoimmune Disease Diagnostics Market Size by Region (2024-2034) & (US$ Million)
Table 166. Asia-Pacific Autoimmune Disease Diagnostics Market Share by Region (2024-2024)
Table 167. Asia-Pacific Autoimmune Disease Diagnostics Market Share by Region (2024-2034)
Table 168. Latin America Autoimmune Disease Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 169. Latin America Autoimmune Disease Diagnostics Market Size by Country (2024-2024) & (US$ Million)
Table 170. Latin America Autoimmune Disease Diagnostics Market Size by Country (2024-2034) & (US$ Million)
Table 171. Middle East & Africa Autoimmune Disease Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 172. Middle East & Africa Autoimmune Disease Diagnostics Market Size by Country (2024-2024) & (US$ Million)
Table 173. Middle East & Africa Autoimmune Disease Diagnostics Market Size by Country (2024-2034) & (US$ Million)
Table 174. Autoimmune Disease Diagnostics Market Trends
Table 175. Autoimmune Disease Diagnostics Market Drivers
Table 176. Autoimmune Disease Diagnostics Market Challenges
Table 177. Autoimmune Disease Diagnostics Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Autoimmune Disease Diagnostics Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Autoimmune Disease Diagnostics Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Autoimmune Disease Diagnostics Market Share by Regions: 2022 VS 2034
Figure 4. Global Autoimmune Disease Diagnostics Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Autoimmune Disease Diagnostics Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Autoimmune Disease Diagnostics Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Autoimmune Disease Diagnostics Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Autoimmune Disease Diagnostics Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Autoimmune Disease Diagnostics Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Analyzers
Figure 11. Global Analyzers Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of Assay Kits
Figure 13. Global Assay Kits Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Global Autoimmune Disease Diagnostics Market Size Share by Type: 2022 & 2034
Figure 15. North America Autoimmune Disease Diagnostics Revenue Market Share by Type (2024-2034)
Figure 16. Europe Autoimmune Disease Diagnostics Revenue Market Share by Type (2024-2034)
Figure 17. Asia-Pacific Autoimmune Disease Diagnostics Revenue Market Share by Type (2024-2034)
Figure 18. Latin America Autoimmune Disease Diagnostics Revenue Market Share by Type (2024-2034)
Figure 19. Middle East and Africa Autoimmune Disease Diagnostics Revenue Market Share by Type (2024-2034)
Figure 20. Hospitals Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 21. Research Laboratories Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 22. Global Autoimmune Disease Diagnostics Market Size Share by Application: 2022 & 2034
Figure 23. North America Autoimmune Disease Diagnostics Revenue Market Share by Application (2024-2034)
Figure 24. Europe Autoimmune Disease Diagnostics Revenue Market Share by Application (2024-2034)
Figure 25. Asia-Pacific Autoimmune Disease Diagnostics Revenue Market Share by Application (2024-2034)
Figure 26. Latin America Autoimmune Disease Diagnostics Revenue Market Share by Application (2024-2034)
Figure 27. Middle East and Africa Autoimmune Disease Diagnostics Revenue Market Share by Application (2024-2034)
Figure 28. Autoimmune Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 29. Global Top 5 and Top 10 Players Autoimmune Disease Diagnostics Market Share in 2022
Figure 30. North America Autoimmune Disease Diagnostics Market Share by Country (2024-2034)
Figure 31. U.S. Autoimmune Disease Diagnostics Market Size (2024-2034) & (US$ Million)
Figure 32. Canada Autoimmune Disease Diagnostics Market Size (2024-2034) & (US$ Million)
Figure 33. Germany Autoimmune Disease Diagnostics Market Size (2024-2034) & (US$ Million)
Figure 34. France Autoimmune Disease Diagnostics Market Size (2024-2034) & (US$ Million)
Figure 35. U.K. Autoimmune Disease Diagnostics Market Size (2024-2034) & (US$ Million)
Figure 36. Italy Autoimmune Disease Diagnostics Market Size (2024-2034) & (US$ Million)
Figure 37. Russia Autoimmune Disease Diagnostics Market Size (2024-2034) & (US$ Million)
Figure 38. Nordic Countries Autoimmune Disease Diagnostics Market Size (2024-2034) & (US$ Million)
Figure 39. Asia-Pacific Autoimmune Disease Diagnostics Market Share by Region (2024-2034)
Figure 40. China Autoimmune Disease Diagnostics Market Size (2024-2034) & (US$ Million)
Figure 41. Japan Autoimmune Disease Diagnostics Market Size (2024-2034) & (US$ Million)
Figure 42. South Korea Autoimmune Disease Diagnostics Market Size (2024-2034) & (US$ Million)
Figure 43. Southeast Asia Autoimmune Disease Diagnostics Market Size (2024-2034) & (US$ Million)
Figure 44. India Autoimmune Disease Diagnostics Market Size (2024-2034) & (US$ Million)
Figure 45. Australia Autoimmune Disease Diagnostics Market Size (2024-2034) & (US$ Million)
Figure 46. Latin America Autoimmune Disease Diagnostics Market Share by Country (2024-2034)
Figure 47. Mexico Autoimmune Disease Diagnostics Market Size (2024-2034) & (US$ Million)
Figure 48. Brazil Autoimmune Disease Diagnostics Market Size (2024-2034) & (US$ Million)
Figure 49. Middle East & Africa Autoimmune Disease Diagnostics Market Share by Country (2024-2034)
Figure 50. Turkey Autoimmune Disease Diagnostics Market Size (2024-2034) & (US$ Million)
Figure 51. Saudi Arabia Autoimmune Disease Diagnostics Market Size (2024-2034) & (US$ Million)
Figure 52. UAE Autoimmune Disease Diagnostics Market Size (2024-2034) & (US$ Million)
Figure 53. Bottom-up and Top-down Approaches for This Report